Vertex stock rockets to record, boosting market cap by $8 billion
July 19, 2017 at 09:57 AM EDT
Vertex Pharmaceuticals Inc. shares soared, adding over $8 billion to the company’s value, as the biotech drug maker announced positive results from clinical studies of its cystic fibrosis treatments, and boosted the company’s probability of becoming a buyout target, according to one analyst.
